{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:56:24Z","timestamp":1787003784838,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43023-8","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:24:53Z","timestamp":1772900693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ACSL4 mediates ferroptosis to promote immunoglobulin A nephropathy progression: scRNA-seq analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Ningjun","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuibi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"5","key":"43023_CR1","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ki.2015.252","volume":"88","author":"R Magistroni","year":"2015","unstructured":"Magistroni, R., D\u2019Agati, V. D., Appel, G. B. & Kiryluk, K. New developments in the genetics, pathogenesis, and therapy of IgA nephropathy. Kidney Int. 88 (5), 974\u2013989. https:\/\/doi.org\/10.1038\/ki.2015.252 (2015). Epub 2015 Sep 16. PMID: 26376134; PMCID: PMC4653078.","journal-title":"Kidney Int."},{"key":"43023_CR2","doi-asserted-by":"publisher","first-page":"1372824","DOI":"10.3389\/fendo.2024.1372824","volume":"15","author":"B Yang","year":"2024","unstructured":"Yang, B. et al. The predictive value of free thyroxine combined with tubular atrophy\/interstitial fibrosis for poor prognosis in patients with IgA nephropathy. Front. Endocrinol. (Lausanne). 15, 1372824 (2024). PMID: 38808109; PMCID: PMC11130362.","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"10","key":"43023_CR3","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1681\/ASN.2011050464","volume":"22","author":"H Suzuki","year":"2011","unstructured":"Suzuki, H. et al. The pathophysiology of IgA nephropathy. J. Am. Soc. Nephrol. 22 (10), 1795\u20131803. https:\/\/doi.org\/10.1681\/ASN.2011050464 (2011). Epub 2011 Sep 23. PMID: 21949093; PMCID: PMC3892742.","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"43023_CR4","doi-asserted-by":"publisher","first-page":"e28509","DOI":"10.1016\/j.heliyon.2024.e28509","volume":"10","author":"Y Xing","year":"2024","unstructured":"Xing, Y. et al. Glomerular IgG deposition predicts kidney disease progression in IgA nephropathy. Heliyon 10 (7), e28509 (2024). PMID: 38571652; PMCID: PMC10988001.","journal-title":"Heliyon"},{"key":"43023_CR5","doi-asserted-by":"crossref","unstructured":"Kiryluk, K. & Novak, J. The genetics and immunobiology of IgA nephropathy. J Clin Invest. 124(6):2325-32. doi: 10.1172\/JCI74475. Epub 2014 Jun 2. PMID: 24892706; PMCID: PMC4089454. (2014).","DOI":"10.1172\/JCI74475"},{"issue":"1","key":"43023_CR6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s42003-023-05272-5","volume":"6","author":"Y Dai","year":"2023","unstructured":"Dai, Y. et al. Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease. Commun. Biol. 6 (1), 907. https:\/\/doi.org\/10.1038\/s42003-023-05272-5 (2023). PMID: 37670055; PMCID: PMC10480178.","journal-title":"Commun. Biol."},{"issue":"10","key":"43023_CR7","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1016\/j.ymthe.2023.07.026","volume":"31","author":"L Gao","year":"2023","unstructured":"Gao, L. et al. STING\/ACSL4 axis-dependent ferroptosis and inflammation promote hypertension-associated chronic kidney disease. Mol. Ther. 31 (10), 3084\u20133103 (2023). Epub 2023 Aug 2. PMID: 37533255; PMCID: PMC10556226.","journal-title":"Mol. Ther."},{"issue":"10","key":"43023_CR8","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.3390\/biomedicines11102692","volume":"11","author":"L Li","year":"2023","unstructured":"Li, L. et al. YAP\/ACSL4 Pathway-Mediated Ferroptosis Promotes Renal Fibrosis in the Presence of Kidney Stones. Biomedicines 11 (10), 2692. https:\/\/doi.org\/10.3390\/biomedicines11102692 (2023). PMID: 37893066; PMCID: PMC10603838.","journal-title":"Biomedicines"},{"issue":"12","key":"43023_CR9","doi-asserted-by":"publisher","first-page":"10021","DOI":"10.3390\/ijms241210021","volume":"24","author":"B Jia","year":"2023","unstructured":"Jia, B., Li, J., Song, Y. & Luo, C. ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries. Int. J. Mol. Sci. 24 (12), 10021. https:\/\/doi.org\/10.3390\/ijms241210021 (2023). PMID: 37373168; PMCID: PMC10298642.","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"43023_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000514183","volume":"46","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy. Kidney Blood Press. Res. 46 (3), 286\u2013297 (2021). Epub 2021 Apr 16. PMID: 33866316.","journal-title":"Kidney Blood Press. Res."},{"key":"43023_CR11","doi-asserted-by":"publisher","first-page":"645988","DOI":"10.3389\/fimmu.2021.645988","volume":"12","author":"R Tang","year":"2021","unstructured":"Tang, R. et al. A Partial Picture of the Single-Cell Transcriptomics of Human IgA Nephropathy. Front. Immunol. 12, 645988. https:\/\/doi.org\/10.3389\/fimmu.2021.645988 (2021). PMID: 33936064; PMCID: PMC8085501.","journal-title":"Front. Immunol."},{"issue":"D1","key":"43023_CR12","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025). PMID: 39417505; PMCID: PMC11701520.","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"43023_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41419-022-04628-9","volume":"13","author":"L Ni","year":"2022","unstructured":"Ni, L., Yuan, C. & Wu, X. Targeting ferroptosis in acute kidney injury. Cell. Death Dis. 13 (2), 182. https:\/\/doi.org\/10.1038\/s41419-022-04628-9 (2022). PMID: 35210424; PMCID: PMC8873203.","journal-title":"Cell. Death Dis."},{"key":"43023_CR14","doi-asserted-by":"publisher","unstructured":"Martin-Sanchez, D. et al. Ferroptosis and kidney disease. Nefrologia (Engl Ed). 40(4):384\u2013394. English, Spanish. (2020). https:\/\/doi.org\/10.1016\/j.nefro.2020.03.005","DOI":"10.1016\/j.nefro.2020.03.005"},{"key":"43023_CR15","doi-asserted-by":"publisher","first-page":"102262","DOI":"10.1016\/j.redox.2022.102262","volume":"51","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury. Redox Biol. 51, 102262 (2022). Epub 2022 Feb 9. PMID: 35180475; PMCID: PMC8857079.","journal-title":"Redox Biol."},{"key":"43023_CR16","doi-asserted-by":"publisher","first-page":"782466","DOI":"10.3389\/fphar.2022.782466","volume":"13","author":"WH Tao","year":"2022","unstructured":"Tao, W. H. et al. Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia\/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via \u03b12-AR. Front. Pharmacol. 13, 782466. https:\/\/doi.org\/10.3389\/fphar.2022.782466 (2022). PMID: 35873574; PMCID: PMC9307125.","journal-title":"Front. Pharmacol."},{"issue":"4","key":"43023_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41419-022-04770-4","volume":"13","author":"W Li","year":"2022","unstructured":"Li, W., Xiang, Z., Xing, Y., Li, S. & Shi, S. Mitochondria bridge HIF signaling and ferroptosis blockage in acute kidney injury. Cell. Death Dis. 13 (4), 308. https:\/\/doi.org\/10.1038\/s41419-022-04770-4 (2022). PMID: 35387983; PMCID: PMC8986825.","journal-title":"Cell. Death Dis."},{"issue":"1","key":"43023_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41419-020-03362-4","volume":"12","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI. Cell. Death Dis. 12 (1), 65. https:\/\/doi.org\/10.1038\/s41419-020-03362-4 (2021). PMID: 33431801; PMCID: PMC7801434.","journal-title":"Cell. Death Dis."},{"issue":"6","key":"43023_CR19","first-page":"840","volume":"50","author":"YJ Bai","year":"2019","unstructured":"Bai, Y. J. et al. [Regulation of Chrysophanol-mediated TLR4\/NF-\u03baB Pathway on Renal Injury and Immune Response in IgA Nephropathy Rats]. Sichuan Da Xue Xue Bao Yi Xue Ban. 50 (6), 840\u2013846 (2019). Chinese. PMID: 31880115.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"43023_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1681\/ASN.2015121376","volume":"28","author":"D Martin-Sanchez","year":"2017","unstructured":"Martin-Sanchez, D. et al. Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid-Induced AKI. J. Am. Soc. Nephrol. 28 (1), 218\u2013229 (2017). Epub 2016 Jun 27. PMID: 27352622; PMCID: PMC5198282.","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"43023_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41419-020-2256-z","volume":"11","author":"Z Hu","year":"2020","unstructured":"Hu, Z. et al. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis. Cell. Death Dis. 11 (1), 73. https:\/\/doi.org\/10.1038\/s41419-020-2256-z (2020). PMID: 31996668; PMCID: PMC6989512.","journal-title":"Cell. Death Dis."},{"issue":"4","key":"43023_CR22","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.7150\/ijbs.80775","volume":"19","author":"Q Lin","year":"2023","unstructured":"Lin, Q. et al. Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS\/HO-1\/GPX4 axis. Int. J. Biol. Sci. 19 (4), 1192\u20131210. https:\/\/doi.org\/10.7150\/ijbs.80775 (2023). PMID: 36923942; PMCID: PMC10008689.","journal-title":"Int. J. Biol. Sci."},{"key":"43023_CR23","doi-asserted-by":"publisher","first-page":"1039241","DOI":"10.3389\/fimmu.2022.1039241","volume":"13","author":"D Zheng","year":"2022","unstructured":"Zheng, D. et al. ROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis. Front. Immunol. 13, 1039241. https:\/\/doi.org\/10.3389\/fimmu.2022.1039241 (2022). PMID: 36389728; PMCID: PMC9663996.","journal-title":"Front. Immunol."},{"key":"43023_CR24","doi-asserted-by":"crossref","unstructured":"Wrighting, D. M. & Andrews, N. C. Interleukin-6 induces hepcidin expression through STAT3. Blood. 108(9):3204-9. doi: 10.1182\/blood-2006-06-027631. (2006) Epub. PMID: 16835372; PMCID: PMC1895528.","DOI":"10.1182\/blood-2006-06-027631"},{"key":"43023_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2021.12.011","volume":"527","author":"M Li","year":"2022","unstructured":"Li, M., Jin, S., Zhang, Z., Ma, H. & Yang, X. Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma. Cancer Lett. 527, 28\u201340 (2022). Epub 2021 Dec 10. PMID: 34902522.","journal-title":"Cancer Lett."},{"issue":"2","key":"43023_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3892\/or.2023.8693","volume":"51","author":"X Xu","year":"2024","unstructured":"Xu, X. et al. SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1. Oncol. Rep. 51 (2), 34. https:\/\/doi.org\/10.3892\/or.2023.8693 (2024). Epub 2024 Jan 8. PMID: 38186303; PMCID: PMC10777466.","journal-title":"Oncol. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43023-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43023-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43023-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:01:34Z","timestamp":1776600094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43023-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43023"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43023-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was reviewed and approved by the human research ethics committee of Ningbo Hwa Mei Hospital, University of Chinese Academy of Sciences (SL-NBEY-KY-2022-060-01). All experiments were performed in accordance with relevant named guidelines and regulations. Informed consent was obtained from all participants and\/or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate<!--Emphasis Type='Bold' removed-->\/Consent to publish"}}],"article-number":"12543"}}